News
A promising new cancer technology from NIH could help improve how liver cancer is diagnosed and treated. Liver cancer, particularly hepatocellular carcinoma (HCC), remains one of the deadliest cancers worldwide, and better treatment options are urgently needed. NIH inventors have developed two fully
World Intellectual Property (IP) Day is April 25th. This is a global event dedicated to industry inventors, creators, and entrepreneurs and how they achieve their goals through the use of IP. To celebrate, the Licensing Executives Society (LES) is hosting a free webinar to bring people together
In just eight years, the NIH National Institute of Allergy and Infectious Diseases moved from identifying an ultra-rare genetic disorder, CD55 deficiency, hyperactivation of the complement, angiopathic thrombosis, and protein-losing enteropathy (CHAPLE) to FDA approval of its first treatment option
Learn from NIH’s Steve Ferguson during the Licensing Executives Society (LES) Industry, Universities and Government virtual course. Ferguson is a Special Advisor at OTT and brings 30+ years of experience on how to set up successful partnerships with NIH and utilize a variety of available